EUVIMEDEUVIMED entdecken
Crossref

Gene Therapy Products Approved in 2022

Sümbül Yıldırım

Gene Editing · 2022

DOI: 10.29228/genediting.67056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gene Editing, 2022. Verfasst von Sümbül Yıldırım.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yıldırım, S. (2022). Gene Therapy Products Approved in 2022. Gene Editing. https://doi.org/10.29228/genediting.67056

Vancouver

Yıldırım S. Gene Therapy Products Approved in 2022. Gene Editing. 2022. doi:10.29228/genediting.67056

BibTeX
@article{Yldrm2022,
  author = {Yıldırım, Sümbül},
  title = {Gene Therapy Products Approved in 2022},
  journal = {Gene Editing},
  year = {2022},
  doi = {10.29228/genediting.67056}
}
Kostenlos starten →